The North America Clinical Trials Matching Software Market would witness market growth of 12.9% CAGR during the forecast period (2023-2030).
Pharmaceutical companies, biotechnology firms, contract research organizations (CROs), and manufacturers of medical devices routinely conduct clinical trials to assess the safety and effectiveness of innovative drugs, diagnoses, and therapies. The increasing numbers of chronic diseases and the rising demand for clinical trials are anticipated to contribute to the market's growth. Patient recruitment and matching are essential to clinical trials, so more clinical trials are being conducted in developing regions.
Patient matching is a crucial factor as clinical trials are conducted on humans. A proper candidate match can save time for sponsors, resulting in optimal outcomes. A significant number of pharmaceutical companies, research institutions, and hospitals are transitioning to virtual or remote trials. These trials do not necessitate travel to sites; the entire procedure is conducted online. Consequently, the future of clinical trials resides in clinical trial management systems and software for patient matching. Automated systems like this eliminate the need for human intervention and thus contribute to the rising demand for patient-matching software.
The adoption of clinical trials management software (CTMS) in North America has been significant due to several factors, including a well-established clinical research industry, a strong emphasis on technological innovation, and the need for efficient and compliant clinical trial management. North America boasts a robust healthcare infrastructure, with numerous research institutions, academic medical centres, and pharmaceutical companies conducting clinical trials. This creates a high demand for CTMS solutions to streamline trial processes. As a result, many CTMS vendors in the region develop cutting-edge solutions that appeal to the clinical research community.
The US market dominated the North America Clinical Trials Matching Software Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $127,155.4 Thousands by 2030. The Canada market is experiencing a CAGR of 15.5% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 14.5% during (2023 - 2030).
Based on Deployment Mode, the market is segmented into Web & Cloud-based, and On-premises. Based on End-use, the market is segmented into Pharmaceutical & Biotechnology Companies, CROs, and Medical Device Firms. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Clinical Trials Matching Software Market is Predict to reach $362.7 Million by 2030, at a CAGR of 13.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Clario, IBM Corporation, Antidote Technologies, Inc., Ofni Systems Inc., Advarra, Inc., ArisGlobal LLC (Nordic Capital Limited), Teckro, Inc., BSI Business Systems Integration AG, Clinical Trials Mobile Application, Optimapharm d.o.o.
Scope of the Study
Market Segments Covered in the Report:
By Deployment Mode
- Web & Cloud-based
- On-premises
By End-use
- Pharmaceutical & Biotechnology Companies
- CROs
- Medical Device Firms
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Clario
- IBM Corporation
- Antidote Technologies, Inc.
- Ofni Systems Inc.
- Advarra, Inc.
- ArisGlobal LLC (Nordic Capital Limited)
- Teckro, Inc.
- BSI Business Systems Integration AG
- Clinical Trials Mobile Application
- Optimapharm d.o.o.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Clinical Trials Matching Software Market, by Deployment Mode
1.4.2 North America Clinical Trials Matching Software Market, by End-use
1.4.3 North America Clinical Trials Matching Software Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.1 Porter’s Five Force Analysis
Chapter 4. North America Clinical Trials Matching Software Market, by Deployment Mode
4.1 North America Web & Cloud-based Market, by Country
4.2 North America On-premises Market, by Country
Chapter 5. North America Clinical Trials Matching Software Market, by End-use
5.1 North America Pharmaceutical & Biotechnology Companies Market, by Country
5.2 North America CROs Market, by Country
5.3 North America Medical Device Firms Market, by Country
Chapter 6. North America Clinical Trials Matching Software Market, by Country
6.1 US Clinical Trials Matching Software Market
6.1.1 US Clinical Trials Matching Software Market, by Deployment Mode
6.1.2 US Clinical Trials Matching Software Market, by End-use
6.2 Canada Clinical Trials Matching Software Market
6.2.1 Canada Clinical Trials Matching Software Market, by Deployment Mode
6.2.2 Canada Clinical Trials Matching Software Market, by End-use
6.3 Mexico Clinical Trials Matching Software Market
6.3.1 Mexico Clinical Trials Matching Software Market, by Deployment Mode
6.3.2 Mexico Clinical Trials Matching Software Market, by End-use
6.4 Rest of North America Clinical Trials Matching Software Market
6.4.1 Rest of North America Clinical Trials Matching Software Market, by Deployment Mode
6.4.2 Rest of North America Clinical Trials Matching Software Market, by End-use
Chapter 7. Company Profiles
7.1 Clario
7.1.1 Company Overview
7.1.2 Recent strategies and developments:
7.1.2.1 Partnerships, Collaborations, and Agreements:
7.1.3 SWOT Analysis
7.2 IBM Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 SWOT Analysis
7.3 Antidote Technologies, Inc.
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Partnerships, Collaborations, and Agreements:
7.3.3 SWOT Analysis
7.4 Ofni Systems Inc.
7.4.1 Company Overview
7.4.2 SWOT Analysis
7.5 Advarra, Inc.
7.5.1 Company Overview
7.5.2 SWOT Analysis
7.6 ArisGlobal LLC (Nordic Capital Limited)
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Geographical Expansions:
7.6.3 SWOT Analysis
7.7 Teckro, Inc.
7.7.1 Company Overview
7.7.2 SWOT Analysis
7.8 BSI Business Systems Integration AG
7.8.1 Company Overview
7.8.2 SWOT Analysis
7.9 Clinical Trials Mobile Application
7.9.1 Company Overview
7.9.2 SWOT Analysis
7.10. Optimapharm d.o.o.
7.10.1 Company Overview
7.10.2 SWOT Analysis
TABLE 1 North America Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
TABLE 2 North America Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
TABLE 3 North America Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
TABLE 4 North America Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
TABLE 5 North America Web & Cloud-based Market, by Country, 2019 - 2022, USD Thousands
TABLE 6 North America Web & Cloud-based Market, by Country, 2023 - 2030, USD Thousands
TABLE 7 North America On-premise Market, by Country, 2019 - 2022, USD Thousands
TABLE 8 North America On-premise Market, by Country, 2023 - 2030, USD Thousands
TABLE 9 North America Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
TABLE 10 North America Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
TABLE 11 North America Pharmaceutical & Biotechnology Companies Market, by Country, 2019 - 2022, USD Thousands
TABLE 12 North America Pharmaceutical & Biotechnology Companies Market, by Country, 2023 - 2030, USD Thousands
TABLE 13 North America CROs Market, by Country, 2019 - 2022, USD Thousands
TABLE 14 North America CROs Market, by Country, 2023 - 2030, USD Thousands
TABLE 15 North America Medical Device Firms Market, by Country, 2019 - 2022, USD Thousands
TABLE 16 North America Medical Device Firms Market, by Country, 2023 - 2030, USD Thousands
TABLE 17 North America Clinical Trials Matching Software Market, by Country, 2019 - 2022, USD Thousands
TABLE 18 North America Clinical Trials Matching Software Market, by Country, 2023 - 2030, USD Thousands
TABLE 19 US Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
TABLE 20 US Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
TABLE 21 US Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
TABLE 22 US Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
TABLE 23 US Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
TABLE 24 US Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
TABLE 25 Canada Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
TABLE 26 Canada Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
TABLE 27 Canada Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
TABLE 28 Canada Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
TABLE 29 Canada Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
TABLE 30 Canada Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
TABLE 31 Mexico Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
TABLE 32 Mexico Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
TABLE 33 Mexico Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
TABLE 34 Mexico Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
TABLE 35 Mexico Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
TABLE 36 Mexico Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
TABLE 37 Rest of North America Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
TABLE 38 Rest of North America Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
TABLE 39 Rest of North America Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
TABLE 40 Rest of North America Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
TABLE 41 Rest of North America Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
TABLE 42 Rest of North America Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
TABLE 43 Key Information – Clario
TABLE 44 Key Information – IBM Corporation
TABLE 45 Key Information – Antidote Technologies, Inc.
TABLE 46 Key Information – Ofni Systems Inc.
TABLE 47 Key Information – Advarra, Inc.
TABLE 48 Key Information – ArisGlobal LLC
TABLE 49 Key Information – Teckro, Inc.
TABLE 50 Key Information – BSI Business Systems Integration AG
TABLE 51 Key Information – Clinical Trials Mobile Application
TABLE 52 Key Information – Optimapharm d.o.o.
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Clinical Trials Matching Software Market, 2019 - 2030, USD Thousands
FIG 3 Key Factors Impacting Clinical Trials Matching Software Market
FIG 4 Porter’s Five Force Analysis: Clinical Trials Matching Software Market
FIG 5 North America Clinical Trials Matching Software Market share, by Deployment Mode, 2022
FIG 6 North America Clinical Trials Matching Software Market share, by Deployment Mode, 2030
FIG 7 North America Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2030, USD Thousands
FIG 8 North America Clinical Trials Matching Software Market share, by End-use, 2022
FIG 9 North America Clinical Trials Matching Software Market share, by End-use, 2030
FIG 10 North America Clinical Trials Matching Software Market, by End-use, 2019 - 2030, USD Thousands
FIG 11 North America Clinical Trials Matching Software Market share, by Country, 2022
FIG 12 North America Clinical Trials Matching Software Market share, by Country, 2030
FIG 13 North America Clinical Trials Matching Software Market, by Country, 2019 - 2030, USD Thousands
FIG 14 SWOT Analysis: Clario
FIG 15 SWOT Analysis: IBM Corporation
FIG 16 SWOT Analysis: Antidote Technologies, Inc.
FIG 17 SWOT Analysis: Ofni Systems Inc.
FIG 18 SWOT Analysis: Advarra, Inc.
FIG 19 SWOT Analysis: ArisGlobal LLC
FIG 20 SWOT Analysis: Teckro, Inc.
FIG 21 SWOT Analysis: BSI Business Systems Integration AG
FIG 22 SWOT Analysis: Clinical Trials Mobile Application
FIG 23 SWOT Analysis: Optimapharm d.o.o.